. .
Acellular 1 -)
Benign c y s t 1 Thyroglossal duct 1 Benign -Gravest
( r e c u r r e n t ) 1 FOLLOWY No surgery 6
Benign 4 =>Graves (postop) 1 (35%)
Nodule p e r s i s t s 2 None 2 Acellular 2
Normal t o p a l p a t i o n 1 We conclude t h a t FNA may be used f o r diagnostic evaluation of thyroid nodules i n c h i l d r e n and may reduce the number of p a t i e n t s r e q u i r i n g s u r g i c a l biopsy. W e have described a biphasic dose-response curve f o r e t h i n y l e s t r a d i o l (EE2) on s h o r t term growth i n p a t i e n t s with Turner's syndrome. To i n v e s t i g a t e whether t h e r e i s a s i m i l a r phenomenon i n boys, we evaluated t h e 3-week ulnar growth v e l o c i t y (TUG) following t h e a d m i n i s t r a t i o n of d i f f e r e n t doses of EE2 t o boys with delayed adolescence. Basal TUG was determined i n 5 prep u b e r t a l o r e a r l y p u b e r t a l boys (Tanner s t a g e s 1-11), ages 13 t o 15 years. Subsequently, the boys received a 4-day i.v. i n f us i o n of EE2 a t each of 3 doses, 4, 20 and 90 &day, given double blind i n a randomized sequence. The TUG was determined before and a f t e r each i n f u s i o n , and was allowed t o r e t u r n t o b a s e l i n e before giving t h e second and t h i r d infusions. Results (mean + -SE) a r e shown i n t h e W e observed an inverse r e l a t i o n s h i p between EEg dose and the increase i n TUG. Mean TUG increased following a l i EE2 i n f u s i o n s , b u t was s i g n i f i c a n t l y higher a f t e r t h e 4 g / d a y EE2 infusion. I n cont r a s t , somatomedin-C l e v e l s were s i g n i f i c a n t l y higher a f t e r t h e 20 and 90 &day EE2 infusions. W e conclude t h a t small amounts of estrogen can s t i m u l a t e ulnar growth i n boys and may play a r o l e i n t h e male pubertal growth s p u r t . Long-acting LHRH analogues a r e known t o be e f f e c t i v e i n t h e suppression of precocious puberty. We used n a t i v e LHRH administered subcutaneously v i a a p o r t a b l e infusion pump i n an 18-month o l d male i n f a n t with precocious puberty secondary t o a hypothalamic tumor. The hormonal d a t a i n r e l a t i o n t o the therapeut i c management i s summarized i n the t a b l e below. A thyroid hormone binding inhibitor (THBI) which affects the ability of thyroxin binding globulin (TBG) t o bind T4 was first described by Chopra e t a1 as a possible explanation for the low T4 levels observed in some adults patients with non-thyroidal illness. Because low T4 levels a r e likewise a common clinical feature of prematurity, we examined THBI activity in 30 neonates (GA 26-43 weeks, BW 930-4360 grams) using a competitive ligand binding assay in order t o determine whether increased THBI levels might be responsible for the hypothyroxinemia of prematurity. Serum concentrations of T4 and TBG were measured by RIA and the free T4 index calculated. THBI activity was expressed as the % CPM T4 1125 displaced from serum binding protein in the absence of THBI. A THBI index was then calculated, normalizing patients' samples relative t o a baseline (control value of 1.0). Significant positive correlations between THBI activity and birthweight (rz0.76, p< 0.0001) and gestational age (rz0.74, p~0 . 0 0 0 2 ) were noted in infants born between 26 and 39 weeks of gestation, but not in more mature infants. No significant correlations were observed between THBI activity and TBC, T4 and f r e e T4 index in these infants. The results of this study indicate that: 1) increased THBI activity is not a likely etiology for the hypothyroxinemia of prematurity; 2) the activity of THBI increases with fetal maturation until term gestation, and then i t appears t o decline; 3) the relationship between THBI activity, birthweight, gestational age, and systemic illness needs t o be further investigated. 
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IDENTIFICATION OF CALMODULIN
U m e r n 0 O n t a r i o . R e s e a r c h I n s t i t u t e , St. J o s e p h l s ' H o s p i t a l , Department of ~a e d i a t r i c s , London, Ontario.
Prostaglandin E (PGE2) production by human amnion i n c r e a s e s with t h e o n s e t of fabor In women and may i n i t i a t e myometrial cont r a c t i o n s a t term. Amnion PGE2 s n t h e s i s i s ca2'-dependent, but t h e i n t r a c e l l u l a r mechanism of CaSi+action i s obscure. The poss i b i l i t y t h a t t h e i n t r a c e l l u l a r ca2 mediator, calmodulin, plays a r o l e i n PGE2 biosynthesis was explored.
Calmodul in-1 i ke a c t i v i t y was i d e n t i f i e d i n both t h e supernat a n t ( c y t o s o l ) and p e l l e t (microsomes) f r a c t i o n s of the 1 0 5 , 0 0 0~9 amnion homogenate a s assessed by t h e i r a b i l i t y t o s t i m u l a t e t h e a c t i v i t y of CAMP phosphodiesterase (PDE). The a c t i v i t y of cytosol p r o t e i n was g r e a t e r c o n s i s t e n t l y than t h a t of microsomal p r o t e i n i n paired samples. Removal of Ca2' from t h e incubation medium by t h e Ca2+ c h e l a t o r , EGTA, decreased cytosol proteinstimulated PDE a c t i v i t y t o basal level s. Three s t r u c t u r a l l y d i f f e r e n t calmodul i n i n h i b i t o r s , t r i f l u o p e r a z i n e (TFP) , cal midazolium and W 7 each i n h i b i t e d cytosol protein-stimulated PDE a c t i v i t y . The 50% i n h i b i t o r y concentrations were: calmidazol ium (O.lluM), TFP (6.7uM) and W 7 (24.0uM). Basal PGE2 output by dispersed amnion c e l l s was i n h i b i t e d a1 so by calmidazol ium and TFP (calmidazolium > TFP) but not by W7. The Ca2+ ionophore, A23187 (lOuM), stimulated PGE2 output, and t h i s was i n h i b i t e d by TFP. I t i s concluded t h a t human amnion contains calmodulin which may mediate, i n p a r t , Ca2+-dependent PGE2 biosynthesis. 
-----
The paradoxical r i s e i n t e s t o s t e r o n e a f t e r almost f u l l suppression can be explained on t h e b a s i s of needle dislodgement Group because of t h e increased a c t i v i t y i n t h i s p a t i e n t ' s age group.
------. . ----~ From our experience, we conclude and recommend t h a t i f LHRH analogues a r e not a v a i l a b l e t o suppress puberty then n a t i v e LHRH &p, A1 kh (lo)/ 1851814 39+7 / 33-1 6 5~4 1 5216 -1 18tZ6 1 3 5 4 2 5 6 &p, ACM def (5) 10445 245* -lW* -23+ -6+ ZXll might be given provided i t can be administered continuously. *pd0.05 -0.001 'mrpatd t o nornkl or hypopit 'with ~m!dl P%TH
